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Interferon-g (IFN-g) is essential for host defense
against intracellular pathogens. Stimulation of innate
immune cells by IFN-g upregulates 2,000 effector
genes such as immunity-related GTPases including
p65 guanylate-binding protein (Gbp) family genes.
We show that a cluster of Gbp genes was required
for host cellular immunity against the intracellular
parasite Toxoplasma gondii. We generated mice
deficient for all six Gbp genes located on chro-
mosome 3 (Gbpchr3) by targeted chromosome
engineering. Mice lacking Gbpchr3 were highly sus-
ceptible to T. gondii infection, resulting in increased
parasite burden in immune organs. Furthermore,
Gbpchr3-deleted macrophages were defective in
IFN-g-mediated suppression of T. gondii intracellular
growth and recruitment of IFN-g-inducible p47
GTPase Irgb6 to the parasitophorous vacuole. In
addition, some members of Gbpchr3 restored the
protective response against T. gondii in Gbpchr3-
deleted cells. Our results suggest that Gbpchr3 play
a pivotal role in anti-T. gondii host defense by
controlling IFN-g-mediated Irgb6-dependent cellular
innate immunity.
INTRODUCTION
Interferon-g (IFN-g) is an important T helper 1 (Th1) cell cytokine
that strongly suppresses the growth and survival of intracellular
pathogens (Boehm et al., 1997). Stimulation of innate immune
cells such as macrophages and dendritic cells by IFN-g results302 Immunity 37, 302–313, August 24, 2012 ª2012 Elsevier Inc.in robust gene expression of a number of effector molecules.
These include immunity-related GTPases such as the Mx
proteins, immunity-related p47 GTPases (Irgs), and p65 guany-
late-binding proteins (Gbps) (Shenoy et al., 2007; Taylor et al.,
2004). Mx proteins have been shown to participate in host
defense against RNA viruses such as influenza and vesicular
stomatitis virus (Sadler and Williams, 2008). Among the Irgs,
mice deficient in Irgm1 (Lrg-47) are highly susceptible to Listeria,
Salmonella, and mycobacteria (Deretic, 2006; MacMicking,
2004). Furthermore, Gbps have recently been shown to induce
antibacterial responses involving phagocytic oxidases, autopha-
gic effectors, and inflammasome (Kim et al., 2011; Shenoy et al.,
2012). Thus, IFN-g-inducible immunity-related GTPases play
pivotal roles in antiviral and antibacterial immune systems.
Toxoplasma gondii is an obligatory intracellular protozoan
parasite that infects virtually all warm-blooded vertebrates
including human and mouse (Boothroyd, 2009; Israelski and
Remington, 1993). Infection of immunocompromised individuals
such as those suffering from AIDS or those being treated with
chemotherapy often leads to fatal toxoplasmosis encephalitis
(Montoya and Remington, 2008). Innate immune cells, which
recognize microbial components mainly via Toll-like receptors
(TLRs) and the chemokine receptor CCR5, are essential in
controlling T. gondii infection via the production of proinflamma-
tory cytokines such as interleukin-12 (IL-12) (Aliberti et al., 2003;
Hunter and Remington, 1995; Yarovinsky and Sher, 2006). IL-12
potentiates polarization of naive T cells to Th1 cells, from which
IFN-g is produced in an antigen-dependent fashion (Trinchieri,
2003; Whitmarsh et al., 2011). IFN-g-inducible GTPases are
also important for the inhibition of T. gondii growth by IFN-g.
Mice lacking Irgm1, Irgd (Irg-47), Irgm3 (Igtp), or Irga6 (Iigp1)
are susceptible to acute and chronic infection (Collazo et al.,
2001; Howard et al., 2011; Taylor et al., 2000). IRGs are recruited
to the parasitophorous vacuole (PV), a membrane formed during
invasion that is maintained to surround the intracellular
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disruption of the integrity of the PV membranes (Howard et al.,
2011; Ling et al., 2006; Taylor et al., 2007; Zhao et al., 2008).
Not only Irgs but also Gbps are known to accumulate around
the PV shortly after T. gondii invasion (Degrandi et al., 2007).
Moreover, because virulent strains of T. gondii inhibit the recruit-
ment of Gbps around the PV (Degrandi et al., 2007; Virreira
Winter et al., 2011), Gbps are considered anti-T. gondii defensive
factors. Among Gbps, Gbp1 and Gbp2 are reported to modulate
cellular proliferation (Gorbacheva et al., 2002; Guenzi et al.,
2001). In addition, Gbp1 is involved in the regulation of matrix
metalloproteinase 1 in cancer cell lines (Guenzi et al., 2003;
Li et al., 2011). Although in vitro studies have been reported,
the physiological protective role of Gbps against T. gondii
remains uncertain. The mouse genome carries 13 Gbp genes
(11 active members and 2 pseudogenes) that are organized in
clusters and share a high degree of homology (Kresse et al.,
2008). Six and seven family members are tandemly aligned on
chromosomes 3 and 5, respectively (Kresse et al., 2008). Such
a complex configuration has hampered in vivo investigation of
the Gbp genes through genetic approaches.
To elucidate the in vivo functional contribution of the Gbps
to host defense against T. gondii, we have generated mice lack-
ing the entire cluster ofGbps on chromosome 3 (Gbpchr3) by Cre-
loxP-based chromosome engineering. Gbpchr3-deleted mice
were highly susceptible to T. gondii infection with a considerably
increased parasite burden in tissues. Furthermore, Gbpchr3-
deleted macrophages showed defective suppression of parasite
growth in response to IFN-g. Although parasite infection-induced
production of oxidants and proinflammatory cytokines as well
as autophagy-related 4b (Atg4b) recruitment to the parasites
were normal, IFN-g-induced disruption of the PV membrane
and localization of Irgs such as Irgb6 and Irgb10 to the PV were
compromised in Gbpchr3-deleted cells. Moreover, endogenous
Gbps colocalized and interacted with Irgb6. The reintroduction
of Gbp1, Gbp5, or Gbp7 into Gbpchr3-deleted cells partially
restored the IFN-g-dependent anti-T. gondii response. Taken
together, these results demonstrate that this cluster of Gbps
has a defensive function against T. gondii by positively regulating
IFN-g-inducible Irgb6-dependent cellular innate immunity.
RESULTS
Generation of Mice Lacking the Entire Gbp Locus
on Chromosome 3
Toassess theanti-T. gondii immunityofGbpchr3 in vivo,wegener-
ated embryonic stem (ES) cells possessing loxP sites at themost
proximal and distal loci from the centromere in the gene cluster
(Gbp5 and Gbp2ps, respectively) by sequential conventional
gene targeting methods (Figure 1A and Figure S1 available
online). Deletion of the entire Gbpchr3 locus spanning 173 kb
was achieved by crossing the F1 mice with CAG-Cre transgenic
mice and was confirmed by Southern blotting and PCR (Figures
1B and 1C). Gbpchr3-deleted mice were successfully obtained
by intercrossing heterozygous mice, were born at the expected
Mendelian ratio, and were healthy and normal in specific-path-
ogen-free conditions (Figure 1D). Under nonstimulated condi-
tions, Gbpchr3-deleted mice showed normal parameters of
cellular immunity (Figure S1H). To test whether the expressionof Gbpchr3 was correctly ablated in Gbpchr3-deleted cells, we
confirmed by quantitative RT-PCR that the mRNAs derived
from Gbpchr3 (Gbp1, Gbp2, Gbp3, Gbp5, Gbp7, and Gbp2ps)
were not induced in response to IFN-g in Gbpchr3-deleted cells
(Figure 1E). On the other hand, mRNAs for the Gbps on chromo-
some 5 (Gbp4, Gbp6, Gbp8, Gbp9, Gbp10, and Gbp11) were
normally induced. We further analyzed Gbpchr3 expression by
protein immunoblotting and found that Gbp1, Gbp2, and Gbp5
proteins were not detected. A weak signal was observed when
we performed blotting with Gbp1-5 monoclonal antibodies that
are raised against amino acids 1–300 mapping at the N terminus
of human GBP1 and that recognize a shared epitope among
Gbp1, Gbp2, Gbp3, Gbp4, and Gbp5. Expression of the gene
encoding Gbp4, which is not disrupted in Gbpchr3-deleted cells,
could account for this weak signal (Figure 1F).
Gbpchr3 Confer Resistance to T. gondii In Vivo
First, mice lackingGbp2ps alone or deficient in bothGbp2ps and
Gbp5 were infected intraperitoneally with the avirulent T. gondii
strain ME49 and shown to exhibit survival rates similar to those
of wild-type mice (Figures S1C and S1F). In contrast, infection
of Gbpchr3-deleted mice revealed that these mutant mice were
highly prone to die after T. gondii infection (Figure 2A). Because
Gbp1 and Gbp5 were recently shown to be involved in host
defense against Listeria monocytogenes (Kim et al., 2011;
Shenoy et al., 2007), we challenged Gbpchr3-deleted mice with
L. monocytogenes by intraperitoneal injection. Wild-type and
Gbpchr3-deleted mice exhibited comparable bacterial burdens
in tissues and survival rate (Figures S2A and S2B). To monitor
the course of infection more accurately, we generated trans-
genic ME49 T. gondii expressing luciferase and monitored the
kinetics by in vivo imaging in wild-type and Gbpchr3-deleted
mice infectedwith 102 parasites. Significant increases in parasite
number were observed at days 7, 8, and 9 in Gbpchr3-deleted
mice compared with those in wild-type mice (Figures 2B and
S2C). We next compared parasite burdens in organs from the
infected mice. The parasite load showed an excellent correlation
with luciferase counts in vitro (Figures S2D and S2E). We
collected the spleens and mesenteric lymph nodes from wild-
type or Gbpchr3-deleted mice 9 days after a challenge with lucif-
erase-expressing parasites and calculated the parasite numbers
according to the luciferase signal. The parasite load in the tissues
originating from Gbpchr3-deleted mice was markedly elevated in
comparison with that from wild-type mice (Figure 2C). Taken
together, these findings demonstrate that Gbpchr3 protects
against the spreading and proliferation of T. gondii in vivo.
Next we examined immune responses during parasite infec-
tion in wild-type and Gbpchr3-deleted mice. IL-12 is important
for the development of type I immunity, in which IFN-g-
producing CD4+ and CD8+ T cells play central roles for anti-
T. gondii responses (Hunter et al., 1995). The concentrations of
IL-12p40 and IFN-g measured in sera were similarly increased
in wild-type and Gbpchr3-deleted mice infected with T. gondii
(Figure 2D). Furthermore, cellularity in spleens and IFN-g
production from splenic CD4+ and CD8+ T cells in response to
anti-CD3 was comparable in wild-type and Gbpchr3-deleted
mice (Figures 2E and S2F), suggesting that the high suscepti-
bility to T. gondii inGbpchr3-deleted mice was not due to defects
in production of IL-12 or IFN-g or in T cell responses.Immunity 37, 302–313, August 24, 2012 ª2012 Elsevier Inc. 303
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Immunity
Anti-Toxoplasma Role of Gbp by Regulating IrgGbpchr3 Are Essential for IFN-g-Induced Reduction
of T. gondii Infection in Macrophages
Macrophages play a vital role in IFN-g-mediated cellular innate
immunity against T. gondii (Suzuki et al., 1988). Peritoneal
macrophages represent a major cell type targeted by the para-
site at the early stage after intraperitoneal infection (Jensen
et al., 2011). To analyze the impact of Gbpchr3 deficiency in this
cell type, we infected wild-type or Gbpchr3-deleted peritoneal
macrophages with T. gondii expressing luciferase in the pres-
ence of IFN-g and assessed the luciferase units at 1, 12, 24,
36, or 48 hr postinfection (Figure 3A). We observed higher
luciferase emissions in Gbpchr3-deleted cells than in wild-type
cells at all time points tested except for 1 hr. Next, we analyzed
the IFN-g-dependent reduction of parasite burden by counting
parasite numbers and the luciferase units in macrophages
and mouse embryonic fibroblasts (MEFs) from wild-type or
Gbpchr3-deleted mice. The dose-dependent reduction of
parasite numbers and luciferase signals in both cell types lacking
Gbpchr3 was less pronounced than that in wild-type cells
(Figures 3B and S3A). On the other hand, costimulation of tumor
necrosis factor-a (TNF-a), which is known to strongly enhance
antitoxoplasmal activity in macrophage in combination with
IFN-g (Sibley et al., 1991), abrogated the difference between
wild-type and Gbpchr3-deleted cells (Figure S3B). These data
suggested a selective impairment in IFN-g-mediated reduction
of parasite burden.
IFN-g leads to inhibition of T. gondii proliferation and promotes
its clearance from macrophages (Ling et al., 2006). To measure
clearance, we next used confocal microscopy to compare the
degree of parasite infection and growth in macrophages isolated
fromwild-type orGbpchr3-deletedmice. At 5 hr postinfection, the
percentage of cells infected with the parasites was comparable
between wild-type and Gbpchr3-deleted mice (Figure 3C). In
contrast, the infection rate of IFN-g-stimulated macrophages
from Gbpchr3-deleted mice was remarkably higher than that
from wild-type cells after 20 hr (Figures 3C, 3D, and S3C).
Next, we compared the rate of parasite replication in wild-type
and Gbpchr3-deleted macrophages in the presence of IFN-g by
counting the parasite numbers per PV. In Gbpchr3-deleted cells,
the number of parasites per PV was modestly increased
compared with that in wild-type cells (Figures 3D and 3E), indi-
cating that Gbpchr3 are not only required for clearance but also
inhibit parasite replication in IFN-g-stimulated macrophages.
Impact of Gbpchr3 Deficiency on IFN-g-Mediated Anti-
T. gondii Response
AmongGbpchr3, Gbp1 andGbp7 have been shown to participate
in antibacterial host defense by inducing an oxidative responseFigure 1. Generation of Gbpchr3-Deleted Mice
(A) The gene targeting strategy for Gbpchr3 locus by chromosome engineering.
(B) Southern blot analysis of offspring from the heterozygote intercrosses. Geno
trophoresed, and hybridized with the radiolabelled probe indicated in Figure S1G.
deleted (D) locus, and 9.6 kb for second targeted locus.
(C) PCR detection of mice with homozygous deletion of Gbpchr3 locus. Primers u
(D) Numbers of offspring by intercross of heterozygous (D/+) mice.
(E) Quantitative PCR analysis of the expression of the indicated Gbp mRNA in wi
stimulated with 100 ng/ml IFN-g.
(F) Peritoneal macrophages treated with 100 ng/ml IFN-g for 24 hr were lysed. T
Data are representative of two (B, C, E) and three (F) independent experiments.and recruiting autophagy effectors such as Atg4b to
L. monocytogenes and Mycobacterium bovis (Kim et al., 2011).
To test whether these mechanisms also apply to anti-T. gondii
defense, we first measured IFN-g-induced oxide ion (O2–)
production in wild-type or Gbpchr3-deleted cells infected with
T. gondii (Figure 4A). The O2– production in Gbpchr3-deleted
macrophages was normally enhanced. Next, we examined
Atg4b recruitment to the parasite by confocal microscopy. As
observed for pathogenic bacteria, Atg4b colocalized with intra-
cellular T. gondii in wild-type cells. The increased recruitment
of Atg4b to parasites in Gbpchr3-deleted macrophages was not
altered during the course of infection (Figures 4B and S4A).
Taken together, these results suggest that the anti-T. gondii
action of Gbpchr3 operates independently of O2– and Atg4b
recruitment.
IFN-g is also known to augment proinflammatory cytokine
production in response to TLR ligands, and T. gondii possesses
a profilin that can serve as a TLR11 ligand called profilin-like
molecule (Plattner et al., 2008; Yarovinsky et al., 2005). We
analyzed the production of proinflammatory cytokines in macro-
phages. Production of tumor necrosis factor a, IL-6, and IL-
12p40 in IFN-g-treated Gbpchr3-deleted cells in response to
T. gondii infection or lipopolysaccharide (LPS) was normal (Fig-
ure S4B), indicating that Gbpchr3 are dispensable for IFN-g-
mediated production of proinflammatory cytokines.
Because nitric oxide (NO) was previously reported to inhibit
T. gondii replication in vitro (Adams et al., 1990), we assessed
NO production in wild-type and Gbpchr3-deleted cells. Nonsti-
mulated, T. gondii-infected, or LPS-treated macrophages from
Gbpchr3-deleted mice produced similar concentrations of nitrite
ion (NO2–) compared with that produced by wild-type cells (Fig-
ure S4C). Furthermore, hepatic expression of iNOS mRNAs was
unchanged between wild-type and Gbpchr3-deleted mice in
T. gondii infection (Figure S4D). In spite of normal NO production
in Gbpchr3-deleted macrophages (Figure S4C), the inhibition of
the parasite replication was modestly impaired by the Gbpchr3
deficiency (Figure 3E). To examinewhether NO is involved in inhi-
bition of parasite replication in Gbpchr3-deleted cells, we
compared the replication inGbpchr3-deleted cells between those
untreated and those treated with aminoguanidine (AG), an NO
inhibitor (Figure 4C). Although the infection rate was not affected
at all, AG-treated Gbpchr3-deleted cells contained significantly
larger numbers of the parasites per vacuole than control cells,
indicating that NO indeed plays a major role in inhibition of
T. gondii replication in Gbpchr3-deleted macrophages in vitro.
To further determine relative importance of Gbpchr3 in the
IFN-g-dependent anti-T. gondii response in vivo, we compared
parasite burdens and the survival rate of wild-type andmic DNA was extracted from mouse tails, digested with KpnI and PstI, elec-
Southern blotting resulted in a 1.5 kb band for wild-type locus, a 2.0 kb band for
sed are denoted in (A).
ld-type (WT) or Gbpchr3-deleted (KO) peritoneal macrophages unstimulated or
he lysates were detected by protein immunoblot with the indicated Abs.
See also Figure S1.
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Figure 2. Gbpchr3-Deleted Mice Are Highly
Susceptible to T. gondii
(A) Wild-type (n = 15) or Gbpchr3-deleted (KO)
(n = 16) mice were infected with 1 3 102 T. gondii,
and the survival rates were monitored for 20 days.
(B) Total photon emission analysis from wild-type
or Gbpchr3-deleted mice (n = 4 per group) infected
with 1 3 102 ME49 T. gondii luciferase-expressing
parasites at days 5, 7, or 8 after infection. The flux
(photons/s/cm2/sr) was determined as a measure
of parasite burden. *p < 0.01, **p < 0.02.
(C) Quantification of parasites in indicated tissues
from 4 mice per group at day 9 postinfection by
the standard curve in Figure S2. Indicated values
are means ± SD of quadruplicates. *p < 0.005,
**p < 0.03.
(D) Sera were taken from indicated mice (n = 4 per
group) at the indicated time postinfection of
1 3 102 T. gondii. Serum concentrations of the
indicated cytokines were determined by ELISA.
(E) Splenic CD4+ or CD8+ T cells from indicated
mice (n = 4 per group) at day 7 postinfection of
1 3 102 T. gondii were cultured in the presence of
5 mg/ml plate-bound anti-CD3 for 24 hr. Concen-
tration of IFN-g in the culture supernatants was
measured by ELISA. Indicated values are means ±
SD of triplicates.
N.D., not detected; N.S., not significant. Data are
representative of three (C) and two (B, D, E)
independent experiments. Data in (A) are pooled
from three independent experiments with five or
six mice per group. See also Figure S2.
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Anti-Toxoplasma Role of Gbp by Regulating IrgGbpchr3-deleted mice treated with anti-IFN-g (Figures 4D and
4E). Although the mortality was not increased by anti-IFN-g
treatment in Gbpchr3-deleted mice (Figure 4D), Gbpchr3-deleted
mice treated with anti-IFN-g displayed much higher parasite
burdens than did control IgG-treated groups (Figure 4E).
These results indicated that Gbpchr3 do not fully account for
the IFN-g-dependent anti-T. gondii immunity in vitro and
in vivo.
Impaired Disruption of the PV Membrane in Gbpchr3-
Deleted Macrophages
Gbpchr3 deficiency resulted in compromised IFN-g-induced
clearance of T. gondii in macrophages (Figure 3). The killing
by IFN-g-activated macrophages is accompanied by blebbing
of the PV membrane shortly after parasite entry (Ling et al.,
2006; Zhao et al., 2008). Therefore, we examined by electron
microcopy the morphology of the parasite PV membrane in
wild-type and Gbpchr3-deleted macrophages 6 hr postinfection.
Blebbing and vesiculation were easily detectable in the vicinity
of the parasite PV membrane in wild-type cells (Figure 5A). In
sharp contrast, in Gbpchr3-deleted cells the parasites were sur-
rounded by a continuous intact PV membrane (Figure 5B), sug-306 Immunity 37, 302–313, August 24, 2012 ª2012 Elsevier Inc.gesting that Gbps affect IFN-g-induced
clearance of T. gondii shortly after inva-
sion. Moreover, 24 hr postinfection,
a markedly increased number of dead
parasites with damaged parasite
membranes or no PV membranes wereobserved in wild-type cells compared with those in Gbpchr3-
deleted cells (Figure 5C and data not shown).
Defective Irgb6 Recruitment to PVs in Gbpchr3-Deleted
Macrophages
A previous study demonstrated that macrophages lacking
the autophagy protein Atg5 exhibit defective blebbing of the
T. gondii PV (Zhao et al., 2008), which is reminiscent of the
phenotype observed in Gbpchr3-deleted cells (Figure 5B). Atg5
has been reported to be required for the recruitment of Irga6 to
the PV (Zhao et al., 2008). Irgs including Irga6 (also known as
IIGP1), Irgb6 (TGTP), and Irgb10 were shown to be phosphory-
lated and dampened by T. gondii ROP18, a parasite-secreted
kinase that acts as a virulence effector molecule (Fentress
et al., 2010; Steinfeldt et al., 2010). The CTG strain of T. gondii
produces an extremely low ROP18 mRNA expression (Boot-
hroyd and Dubremetz, 2008; Saeij et al., 2006; Taylor et al.,
2006); hence the CTG parasites as well as ME49 are permissive
for Irg recruitment to the PV membrane (Saeij et al., 2006; Taylor
et al., 2006). By using the CTG strain expressing luciferase, we
found that the IFN-g-dependent decrease in CTG parasites
was impaired in Gbpchr3-deleted macrophages (Figure 6A),
B4
5
6
12 24 36 48
(hr)
P
a
ra
s
it
e
 n
u
m
b
e
r 
(L
U
 :
 L
o
g
1
0
)
5
6
7
0 0.01 0.1 1 10 100
IFN- (ng/ml)
A
WT
KO
WT
KO
Macrophages
0 0.01 0.1 1 10 100
IFN- (ng/ml)
4
5
6
3
Fibroblasts
1
D OKTW
T. gondii
CD11b
DAPI 
C
0
10
20
30
40
50
20 hr
In
fe
c
ti
o
n
 r
a
te
 (
%
)
5 hr
(Time after infection)
*
1 2 4 8>
Parasites/vacuole
0
20
40
60
80
100
V
a
c
u
o
le
s
 (
%
)
E *
***
**
WT
KO
P
a
ra
s
it
e
 n
u
m
b
e
r 
(L
U
 :
 L
o
g
1
0
)
WT
KO
Figure 3. Impaired IFN-g-Mediated Parasite
Clearance in Gbpchr3-Deleted Macrophages
(A) Wild-type (WT) and Gbpchr3-deleted (KO) peri-
toneal macrophages were treated with 100 ng/ml
IFN-g for 24 hr. IFN-g-treated cells were infected
with ME49 T. gondii expressing lucifease
(moi = 0.5) and harvested at the indicated point
postinfection. The luciferase units (LU) were
assayed with the lysates. Indicated values are
means ± SD of triplicates.
(B) WT and KO peritoneal macrophages or MEFs
were untreated or treated with the indicated
concentrations of IFN-g for 24 hr. Untreated or
IFN-g-treated cells were infected with ME49
T. gondii expressing luciferase (moi = 0.5) and
harvested at 36 hr postinfection. The LU were
assayed with the lysates. Indicated values are
means ± SD of triplicates.
(C) The percentage of WT and KO macrophages
containing at least one T. gondii parasite at the
indicated points postinfection. Indicated values
are means ± SD of triplicates. **p < 0.03.
(D) WT and KO peritoneal macrophages were
treated with 100 ng/ml IFN-g for 24 hr. IFN-g-
treated cells were infected with ME49 T. gondii
(moi = 0.5), fixed at 24 hr postinfection, and stained
with rabbit anti-T. gondii (Alexa 488, green) or rat
anti-Cd11b (Alexa 594, red). Scale bars represent
20 mm.
(E) The number of T. gondii parasites per vacuole
in WT or KO macrophages at 24 hr postinfection.
Indicated values are means ± SD of triplicates.
*p < 0.02, **p < 0.04, ***p < 0.002.
Data are representative of five (A), three (B), and
two (D) independent experiments. Data in (C) and
(E) are pooled from three independent experiments
in which almost 150 cells and 140 vacuoles were
counted, respectively. See also Figure S3.
Immunity
Anti-Toxoplasma Role of Gbp by Regulating Irgsuggesting that Irg-mediated immunity could be affected by
Gbpchr3 deficiency. To test this possibility, we first analyzed
the amount of Irgb6 protein expression in IFN-g-treated macro-
phages. Similar amounts of Irgb6 protein were induced in wild-
type and Gbpchr3-deleted cells upon stimulation by IFN-g (Fig-
ure 6B). Next, we tested the recruitment of Irgb6 to the PV by
confocal microscopy. At 6 hr postinfection, Irgb6was detectable
at the PV in wild-type cells. In contrast, the recruitment of Irgb6
was severely impaired in Gbpchr3-deleted macrophages (Fig-
ure 6C). The extent of Irgb6 recruitment was analyzed at 2, 4,
and 6 hr postinfection. Compared with that in wild-type cells,
the percentage of Irgb6-positive parasites in Gbpchr3-deleted
cells was significantly lower at every time point analyzed (Fig-
ure 6D). In addition to Irgb6, we tested the recruitment of other
Irgs such as Irgb10, Irga6, and Irgm3 (Figure S5). The recruitment
of Irgb10 to the PV was also impaired in Gbpchr3-deleted cells
(Figure S5A), whereas that of Irga6 was comparable betweenImmunity 37, 302–31wild-type and Gbpchr3-deleted cells
(Figures S5B and S5C). We failed to
observe the accumulation of Irgm3 to
the PVs even in IFN-g-stimulated wild-
type cells (data not shown). Taken
together, these results suggest thatGbpchr3 are required for recruitment of Irgb6 and Irgb10 to the
PV of T. gondii in IFN-g-activated macrophages.
Gbps Interact with Irgb6
In a previous study, an overexpressed green fluorescent protein
(GFP)-Gbp1 fusion protein was shown to colocalize with endog-
enous Irgb6 and T. gondii parasites (Virreira Winter et al., 2011).
We confirmed these observations with endogenous proteins by
costaining for anti-Gbp1-5 and anti-Irgb6 in wild-type macro-
phages infected with T. gondii (Figure 6E). Furthermore, intensity
profile analysis revealed that the signals for both proteins were
detected at almost the same sites (Figure 6F). Then, we as-
sessed the interaction between Gbps and Irgb6 in endogenous
settings. Immunoprecipitation with anti-Gbp1-5 coprecipitated
Irgb6 in IFN-g-stimulated macrophages, and the amount of
Irgb6 coimmunoprecipitated was markedly increased upon
T. gondii infection (Figure 6G). These results suggest that the3, August 24, 2012 ª2012 Elsevier Inc. 307
BA
0
1
2
3
4
O
2
-
p
ro
d
u
c
ti
o
n
 (
L
U
 :
 1
0
3
)
Me
d
T
.
g
o
n
d
ii
Me
d
+IFN-
T
.
g
o
n
d
ii
WT
KO
Atg4b T. gondii Merge+DAPI
WT
KO
C
D
0
20
40
60
80
100
S
u
rv
iv
a
l 
ra
te
 (
%
)
0 2 4 6 8 10 12 14 16 18 20
(Day)
E
5
6
7
8
6 7 85
(Day)
0
10
20
30
40
50
In
fe
c
ti
o
n
 r
a
te
 (
%
)
24 hr postinfection
KO - AG
KO - control
WT - AG
WT - control
N.S.
1 2 4 8>
Parasites/vacuole
0
20
40
60
80
100
V
a
c
u
o
le
s
 (
%
)
* ** ***
N
.D
.
N
.D
.
P
a
ra
s
it
e
 b
u
rd
e
n
 (
to
ta
l 
fl
u
x
 :
 L
o
g
1
0
)
-
-
-
-
Figure 4. Assessment of IFN-g-Dependent
Responses in Gbpchr3-Deleted Mice
(A) Wild-type (WT) and Gbpchr3-deleted (KO) peri-
toneal macrophages were treated with 100 ng/ml
IFN-g for 24 hr. Untreated or IFN-g-treated cells
were uninfected or infected with ME49 T. gondii
(moi = 0.5) for 24 hr. Concentration (light unit; LU)
of O2 in cells was measured with an O2-specific
chemiluminescence reagent by luminometer.
Indicated values are means ± SD of triplicates.
(B) WT and KO peritoneal macrophages were
treated with 100 ng/ml IFN-g for 24 hr. IFN-g-
treated cells were infected with ME49 T. gondii
(moi = 0.5), fixed at 6 hr postinfection, and stained
with mouse anti-T. gondii (Alexa 488, green) or
rabbit anti-Atg4b (Alexa 594, red). Scale bars
represent 5 mm.
(C) WT and KO peritoneal macrophages were
untreated or treated with 100 ng/ml IFN-g for 24 hr
in the presence or absence of 100 mM AG. Cells
were infected with ME49 T. gondii expressing
luciferase (moi = 0.5). Left: The number of parasites
per vacuole in WT or KO macrophages at 24 hr
postinfection is shown. Indicated values are
means ± SD of triplicates. *p < 0.01, **p < 0.03.
Right: The percentage of WT and KO macro-
phages containing at least one parasite at 24 hr
postinfection is shown. Indicated values are
means ± SD of triplicates. N.S., not significant.
(D) Mice (WT intraperitoneally injected with 1 mg
of anti-IFN-g [n = 5] or with control IgG [n = 6] and
KO with anti-IFN-g [n = 8] or with control IgG
[n = 8] before 1 day of the parasite challenge) were
intraperitoneally infected with 1 3 102 T. gondii,
and the survival rates were monitored for 20 days.
(E) Total photon emission analysis from indicated
mice (n = 4 per group) infected with 1 3 102
ME49 T. gondii luciferase-expressing parasites at
days 5, 6, 7, or 8 after infection. The flux (photons/
s/cm2/sr) was determined as ameasure of parasite
burden.
Data are representative of two (A, B, C, E) inde-
pendent experiments. Data in (D) are pooled from
two independent experiments. See also Figure S4.
Immunity
Anti-Toxoplasma Role of Gbp by Regulating Irgassociation of Irgb6 with Gbps is fundamental to the defective
Irgb6 recruitment to T. gondii in Gbpchr3-deleted cells.
Gbpchr3 Participate Differentially in Anti-T. gondii
Defense
Although the Gbps share a high degree of homology (Kresse
et al., 2008), variation in the amino acid sequence amongGbpchr3
is greater than that among Gbpchr5. It is uncertain whether the
five active members of Gbpchr3 (Gbp1, Gbp2, Gbp3, Gbp5,
and Gbp7) similarly or differentially contribute to the anti-
T. gondii cellular immunity. To address this question, we cloned
each Gbp into drug-responsive retroviral expression vectors and
expressed them in a tightly doxycycline-dependent manner in
Gbpchr3-deleted primary MEFs (Figure 7A). Parasite clearance
in the absence or presence of IFN-g was then tested in these
transduced cells. Reintroduction of Gbp1, Gbp5, or Gbp7 into
Gbpchr3-deleted MEFs partially restored the IFN-g-dependent
clearance of T. gondii compared with wild-type cells (Figures
3B and 7B), indicating that these proteins possess common308 Immunity 37, 302–313, August 24, 2012 ª2012 Elsevier Inc.and compensatory functions in the anti-T. gondii immune
response. Taken together, our results show that Gbpchr3 play
a pivotal role in IFN-g-mediated cellular innate immune response
to T. gondii.
DISCUSSION
This study makes use of targeted chromosome engineering to
provide genetic evidence for the critical role of Gbpchr3 in
defense against T. gondii infection. Mice lacking Gbpchr3 were
highly susceptible to T. gondii infection, and Gbpchr3-deleted
macrophages are defective in IFN-g-mediated inhibition of intra-
cellular parasite growth.
The Gbp-mediated cellular immune mechanism was previ-
ously reported to be pleiotropic and implicated IFN-g-inducible
phagocytic oxidative killing and the trafficking of antimicrobial
peptides to autophagolysosomes by their interaction with
NADPH oxidase subunits and autophagy-related molecules
such as Atg4b, respectively (Kim et al., 2011). In this previous
Figure 5. Electron Microscopic Analysis
of IFN-g-Activated Macrophages
(A and B) Wild-type (A) or Gbpchr3-deleted (B)
peritoneal macrophages were treated with
100 ng/ml IFN-g for 24 hr. IFN-g-treated cells were
infected withME49 T. gondii (moi = 0.5) for 6 hr and
then analyzed by electron microscopy. The lower
images are enlarged views from the upper images.
Tg, T. gondii; PV, parasitophorous vacuole. Arrows
indicate protrusive blebs inside or outside para-
sitophorous vacuoles (A).
(C) Images of dead parasites at 24 hr postinfection
in IFN-g-treated wild-type cells. Tg, T. gondii.
Scale bars represent 0.2 mm. Data are represen-
tative of two independent experiments.
Immunity
Anti-Toxoplasma Role of Gbp by Regulating Irgstudy, Gbp function was mainly tested with dominant-negative
forms of Gbps or small interfering RNA-mediated knockdown
(Kim et al., 2011). Here, we observed normal O2– production in
response to IFN-g stimulation and Atg4b recruitment to PVs in
Gbpchr3-deleted macrophages. Instead, we found that Gbpchr3
deficiency affected recruitment of some Irgs to T. gondii-infected
macrophages. The discrepancy between the two studies might
be explained by the different pathogens, or alternatively, it is
possible that the other cluster of Gbps on chromosome 5
(Gbpchr5) may play a compensatory role in the oxidative and au-
tophagy-related responses.
Blebbing of the PV membrane was not induced in IFN-g-
activated macrophages lacking Gbpchr3, which is akin to that
observed in Atg5-deficient cells (Zhao et al., 2008). The similar
phenotypes of both mutant mice prompted us to examine the
localization of Irgs during T. gondii infection. Gbpchr3 deficiency
impaired accumulation of Irgb6 and Irgb10 but not of Irga6
around the parasite, suggesting that the Gbps play a major
role in some Irg recruitment. This model contrasts with previous
studies suggesting that Irgs control localization of Gbps based
on the fact that IFN-g prestimulation is required for the localiza-
tion of overexpressed Gbps to T. gondii (Degrandi et al., 2007),
and that Gbp2 localization is altered in Irgm-deficient cells (Tra-Immunity 37, 302–31ver et al., 2011). Considering that Gbps
and Irgs participate in the anti-T. gondii
response in close proximity, it is possible
that the two families of IFN-g-inducible
GTPases mutually control their localiza-
tion, at least in part, through physical
association. Given that the number of
IRGs and GBPs varies among species (2
IRGs and 7 GBPs in human versus 23
Irgs and 13 Gbps in mouse) (Kresse
et al., 2008; Shenoy et al., 2007), evolu-
tionary pressure to increase or decrease
the number and variety of IRGs could
influence the repertoire of GBPs. Further-
more, virulent T. gondii strains such as RH
are capable of evading recognition by Irgs
via the action of the virulence factor
ROP18 that phosphorylates the Irgs (De-
grandi et al., 2007; Fentress et al., 2010;
Steinfeldt et al., 2010; Virreira Winteret al., 2011). In addition, virulent T. gondii also prevents the accu-
mulation of Gbps (Virreira Winter et al., 2011). Taken together,
ROP18 phosphorylation of Irgs could affect the interaction with
Gbps, promoting their dissociation from the parasites. In terms
of the kinetics of the recruitment of Irgb6, given thatGbpchr3 defi-
ciency affected the later phase rather than the early stage,
Gbpchr3 might play a role in persistence of Irgb6 on PVs in the
later stage. Alternatively, other factors including Gbpchr5 might
also participate in the Irgb6 recruitment in the early phase of
infection. Whether deficiency of either Gbpchr3 or Gbpchr5 (or
both) also affects the localization of other Irgs such as Irgm
and Irgd deserves further investigation. Despite the fact that
Irgb6 and Irgb10 are shown to be phosphorylated by ROP18
in vitro (strongly indicating the defensive roles of these Irgs) (Fen-
tress et al., 2010), their in vivo functions in immunity to T. gondii
should still be assessed and confirmed under physiological
conditions via mice lacking these Irgs.
The impaired inhibition of T. gondii replication in Gbpchr3-
deleted cells prompted us to investigate the effect of NO on
the Gbpchr3-dependent resistance to T. gondii in vitro. We found
that the presence or absence of NO did not affect parasite clear-
ance; the rate of macrophages infected with T. gondii was not
altered by addition of the NO inhibitor. Given the collaboration3, August 24, 2012 ª2012 Elsevier Inc. 309
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Figure 6. Defective Irgb6 Recruitment in
Gbpchr3-Deleted Macrophages
(A) Wild-type (WT) and Gbpchr3-deleted (KO) peri-
toneal macrophages were untreated or treated
with the indicated concentrations of IFN-g for
24 hr. Untreated or IFN-g-treated cells were in-
fected with CTG T. gondii expressing luciferase
(moi = 0.5) and harvested at 36 hr postinfection.
The luciferase units (LU) were assayed with the
lysates. Indicated values are means ± SD of
triplicates.
(B) Peritoneal macrophages treated with 100 ng/ml
IFN-g for 24 hr were lysed. The lysates were de-
tected by protein immunoblot with the indicated
Abs.
(C) WT and KO peritoneal macrophages were
treated with 100 ng/ml IFN-g for 24 hr. IFN-g-
treated cells were infected with ME49 T. gondii
(moi = 0.5), fixed at 6 hr postinfection, and incu-
bated with rabbit anti-T. gondii (Alexa 488, green)
or goat anti-Irgb6 (Alexa 594, red). Scale bars
represent 10 mm. Arrows indicate colocalization of
Irgb6 with T. gondii.
(D) The percentage of WT and KO macrophages
positive for Irgb6 staining at the indicated points
postinfection. Indicated values are means ± SD of
triplicates. *p < 0.03, **p < 0.005, ***p < 0.004.
(E and F) Peritoneal macrophages were treated
with 100 ng/ml IFN-g for 24 hr. IFN-g-treated cells
were infected withME49 T. gondii (moi = 0.5), fixed
at 6 hr postinfection, and incubated with rabbit
anti-T. gondii (Alexa 488, green), goat anti-Irgb6
(Alexa 594, red), or mouse anti-Gbp1-5 (Alexa 647,
magenta). The samples were analyzed by confocal
microscopy and subsequent intensity profile (F).
Scale bars represent 5 mm. The signal intensities of
each color on the 10 mmwhite line on the parasites
are shown.
(G) Peritoneal macrophages treatedwith 100 ng/ml
IFN-g for 24 hr were lysed. The lysates were
immunoprecipitated with anti-Gbp1-5 and de-
tected by protein immunoblot with the indicated
antibodies. Asterisk indicates nonspecific.
Data are representative of two (A, B) or three (C, D,
E, F, G) independent experiments. Data in (D) are
pooled from three independent experiments, in
which almost 150 cells at each time point were
counted. See also Figure S5.
Immunity
Anti-Toxoplasma Role of Gbp by Regulating Irgof Irg and Gbp, the NO-independent role of Gbpchr3 may be
parallel to the NO-independent effect of Irg on T. gondii clear-
ance (Collazo et al., 2002). In contrast, the presence of Gbpchr3
had a modest effect on the inhibition of T. gondii replication,
which critically involves NO, because Gbpchr3-deleted macro-
phages contained larger numbers of the parasites per PV.
Because there is no direct evidence indicating a role of Irg in
the suppression of T. gondii replication to date, these data
may be indicative of an unknown Irg-independent mechanism(s)
of Gbpchr3 to promote the NO-mediated inhibition of the parasite
replication in vitro. Nevertheless, considering that iNOS defi-
ciency has a minor effect on early resistance in vivo (Scharton-
Kersten et al., 1997), the high susceptibility in acute T. gondii
infection in Gbpchr3-deleted mice might be due to the defective
parasite clearance dependent on some Irgs. Given the relative
significance of Gbpchr3 in IFN-g-dependent anti-T. gondii310 Immunity 37, 302–313, August 24, 2012 ª2012 Elsevier Inc.responses, the fact that anti-IFN-g treatment in Gbpchr3-deleted
mice resulted in enhanced parasite burdens in vivo suggests that
additional IFN-g-inducible effector(s) controls early resistance
to the parasite. On the other hand,Gbpchr3-deleted mice treated
with anti-IFN-g displayed similar survival rate of mice with
control IgG. The apparent disparity might be because anti-
IFN-g blocked IFN-g-dependent anti-T. gondii response, leading
not only to high parasite burdens but also to immune pathology
mediated by massive and dysregulated doses of IFN-g at the
terminal phase of T. gondii infection (Nguyen et al., 2003).
In addition, costimulation of TNF-awith IFN-g resulted in incom-
parable inhibition of the parasite growth and abolished the
Gbpchr3-mediated effect. Although NO concentration in TNF-a
and IFN-g-treated macrophages was markedly higher than that
in cells stimulated with IFN-g alone, further investigation is
required to determine whether only the difference of NO
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Figure 7. Individual Participation of Gbpchr3 in IFN-g-Dependent
Inhibition of T. gondii Growth
(A) Retroviral vectors encoding the indicated Flag-tagged Gbps were stably
introduced inGbpchr3-deleted (KO) primary MEFs. The transfected MEFs were
treated with or without 1 mg/ml doxycycline (Dox) for 24 hr and lysed. The
lysates were immunoprecipitated with anti-Flag and detected by protein
immunoblot with the indicated antibodies.
(B) The KO MEFs transfected with indicated Gbps were unstimulated or
stimulated with 100 ng/ml of IFN-g for 24 hr with or without 1 mg/ml Dox. Cells
were infected with ME49 T. gondii parasites expressing luciferase (moi = 0.5)
for 36 hr, and the luciferase units (LU) were analyzed. The percentages of the
activities after each Gbp induction with Dox over those without Dox (no Gbp
induction) in nonstimulated (left) or stimulated (right) cells were shown. Indi-
cated values are means ± SD of triplicates.
Data are representative of two independent experiments. *, **, ***p < 0.001.
Immunity
Anti-Toxoplasma Role of Gbp by Regulating Irgconcentration or other NO-independent effects such as autoph-
agy and augmentation of phagocytic activity accounts for the
enhanced protective effect (Keller et al., 2011; Langermans
et al., 1992; Leenen et al., 1994).
Gbp1, Gbp5, and Gbp7, but not Gbp2 or Gbp3, were able
to restore, albeit not fully, the killing activity by IFN-g in
Gbpchr3-deleted MEFs, indicating that Gbpchr3 contribute differ-
entially to the anti-T. gondii host defense mechanism. This is
consistent with a previous finding that knockdown of some
Gbps abrogates IFN-g-dependent suppression of bacterial
growth (Kim et al., 2011). In the context of the functional redun-
dancy within Gbpchr3, we observed that mice lacking Gbp5, or
Gbp5 and Gbp2ps, were resistant to T. gondii infection, sug-
gesting that Gbp5 deficiency may be compensated for by other
Gbpchr3-encoded proteins such as Gbp1 and Gbp7. On the
other hand, mice lacking Gbp1 alone are susceptible to
L. monocytogenes and M. bovis. Interestingly, Gbp5 has
recently been shown to play a key role in the host defense in
L. monocytogenes infection, indicating the nonredundant func-
tion of Gbp1 and Gbp5 in the antibacterial response (Kim
et al., 2011; Shenoy et al., 2012). In contrast, our Gbpchr3-
deleted mice displayed resistance to L. monocytogenes. This
discrepancy may reflect different modes of infection (e.g., oralversus intraperitoneal infections in the previous and current
studies, respectively) or utilization of different mice strains
(Gbp1 or Gbp5 singly deficient mice in previous studies and
Gbpchr3-deleted mice in this study) (Kim et al., 2011; Shenoy
et al., 2012). Moreover, we could not exclude the possibility
that Gbpchr3 other than Gbp1 and Gbp5 play a negative role in
Gbp1- and Gbp5-mediated anti-Listeria response. It remains
to be seen whether deficiency of Gbp1 alone would be sufficient
to disrupt the anti-T. gondii defense system, but it is neverthe-
less plausible that each member of Gbpchr3 may play a differen-
tial role to combat distinct types of pathogens. Given that Gbp2
associates with Gbp1 (Virreira Winter et al., 2011), Gbp2 (and
Gbp3) might play a role in host defense against other pathogens
or have an additional anti-T. gondii effect in the presence of
other Gbpchr3. Considering that Gbpchr3-deleted cells lack
a large genetic region, there is an inherant risk that the pheno-
type observed in Gbpchr3-deleted mice could be unrelated to
Irg. Although we adopted in vitro retroviral transfection for the
restoration of each Gbp in this study, none of Gbpchr3 failed to
fully restore the effect of IFN-g. It remains unclear whether the
failure is due to limit of the transfection method or due to nonre-
dundancy among Gbpchr3 except for Gbp5. In vivo transgenic
reconstitution of the region by an artificial chromosome such
as BAC and YAC should be utilized to reveal a role of each
Gbp specifically participating in antiparasite in vivo responses
in the future (Copeland et al., 2001).
In conclusion, our genetic study with Gbpchr3-deleted mice
has established that Gbpchr3 are required for IFN-g-mediated
host defense against T. gondii by regulating Irgb6 recruitment
to the parasite. To understand the functions of this family of
IFN-g-inducible p65 GTPases fully, future studies will have to
include the second cluster, Gbpchr5, and will need to investigate
the effect of these proteins in defense against a broader range of
parasites, as well as against other pathogens including viruses
and bacteria.EXPERIMENTAL PROCEDURES
Cells, Mice, and Parasites
C57BL/6micewere obtained fromSLC.ME49 andCTGderivatives of T. gondii
were maintained in Vero cells by biweekly passage in RPMI1640 (Nacalai
Tesque) supplemented with 2% heat-inactivated fetal calf serum (JRH Biosci-
ence), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (GIBCO). MyD88-
deficient mice were kindly provided by S. Akira. Animal experiments were
conducted with the approval of the Animal Research Committee of the
Graduate School of Medicine and of the Research Institute for Microbial
Diseases, Osaka University.Reagents
Antibodies against T. gondii (sc-73210), TGTP (Irgb6; sc-11079), Atg4b
(sc-130968), Gbp1 (sc-10586), Gbp2 (sc-10588), Gbp5 (sc-160356), Gbp1-
5 (sc-166960), and actin (sc-8432) were purchased from Santa Cruz. Anti-
CD11b (M1/70) was obtained from Becton Dickinson. Aminoguanidine
hydrochloride, LPS (a TLR4 ligand) from Salmonella minnesota Re 595,
and anti-Flag were purchased from Sigma. Anti-GAP45 rabbit and anti-
MIC2 mouse antibodies were as described previously (Fre´nal et al., 2010).
Anti-Irga6 (165/3) and Irgb10 (940/6) rabbit antibodies and anti-Irgm3
(BD Transduction Laboratories) mouse antibodies were kindly provided by
J. Howard. Anti-IFN-g (BE0055) and control Rat IgG1 (BE0088) were ob-
tained from BioXcell. Recombinant IFN-g and TNF-a were obtained from
Peprotech.Immunity 37, 302–313, August 24, 2012 ª2012 Elsevier Inc. 311
Immunity
Anti-Toxoplasma Role of Gbp by Regulating IrgIn Vivo Measurement of Parasites by Imaging
Mice were intraperitoneally infected with 1 3 102 freshly egressed ME49
tachyzoites expressing luciferase resuspended in 100 ml PBS, and biolumi-
nescence was assessed on the indicated days after infection. Treatment
of anti-IFN-g and control IgG was performed by the intraperitoneal injection
1 day before T. gondii infection. For the detection of bioluminescence
emission, mice were intraperitoneally injected with 3 mg of D-luciferin in
200 ml PBS (Promega), maintained for 5 min to allow adequate dissemination
of the luciferin, then anesthetized with isoflurane (Dainippon Sumitomo
Pharma). At 10 min postinjection of D-luciferin, abdominal photon emission
was assessed during a 60 s exposure by an in vivo imaging system
(IVIS 100; Xenogen) and analyzed as described previously (Yamamoto
et al., 2011).
Immunofluorescence
Peritoneal macrophages (13 106) infected with T. gondii (moi = 0.5) were fixed
for 10 min in PBS containing 3.7% formaldehyde. Cells were permeabilized
with PBS containing 0.1% Triton X-100 and then blocked with 8% fetal calf
serum in PBS. Subsequently, cells were incubated with anti-CD11b rat
antibody (1:200) and anti-GAP45 rabbit antibody (1:1,000) in Figure 3D; anti-
Atg4b rabbit antibody (1:200) and anti-T. gondii mouse antibody (1:50) in
Figure 4B; anti-GAP45 rabbit antibody (1:1,000), anti-Irgb6 goat antibody
(1:50), and anti-Gbp1-5 mouse antibody (1:200) in Figure 6; and anti-Irgb10
or anti-Irga6 rabbit antibody (1:1,000) and anti-MIC2 mouse antibody
(1:1,000), anti-Irgm3 mouse antibody (1:250), and anti-GAP45 rabbit antibody
(1:1,000) in Figure S5, for 1 hr at 37C, followed by incubation with donkey IgG
antibodies (1:10,000): Alexa Fluor 488-conjugated anti-rabbit IgG, Alexa Fluor
594-conjugated anti-goat, or Alexa Fluor 647 or Alexa Fluor 594-conjugated
anti-mouse (Molecular Probes) for 1 hr at room temperature in the dark. Finally,
the immunostained cells were mounted with PermaFluor (Thermo Scientific)
on glass slides and analyzed by confocal laser microscopy (FV1000-D IX-81;
Olympus); the images were analyzed with Fluoview (Olympus).
Transmission Electron Microscopy
Peritoneal macrophages (1 3 106) untreated or treated with 100 ng/ml IFN-g
for 24 hr were infected with T. gondii (moi = 0.5) for 6 or 24 hr. After washing
with PBS, the cells were fixed with 2.5% glutaraldehyde in 0.1 M phosphate
buffer at 4C overnight. The cells were postfixed with 1% OsO4 in the same
buffer at 4C for 1 hr, dehydrated in a graded series of ethanol, and embedded
in Quetol 812 (Nissin EM). Silver sections were cut with an ultramicrotome,
stained with lead citrate and uranyl acetate, and observed with an H-7650
electron microscope (Hitachi).
Statistical Analysis
The unpaired Student’s t test was used to determine the statistical significance
of the experimental data.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
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